Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

Angela Read thought she had a sinus infection, soon she discovered her condition was much more serious. She's grateful to the ...

Ultra-long-acting treatment could reshape respiratory care as EU regulators back GSK's high-stakes depemokimab ahead of 2026 ...

Among seven new medicines recommended for approval by the EMA's human medicine advisory committee at its latest meeting is ...

GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines ...

Coming up in the back half of December, the FDA will issue a verdict on Vanda Pharmaceuticals’ gastroparesis drug tradipitant ...

Winter allergies or chronic sinusitis? On National Pollution Control Day, experts decode how pollution worsens sinus issues ...

Europe’s drug regulator backed GSK Plc’s drug to treat severe asthma or a common nasal condition, in the first such recommendation globally for a medicine that is pegged to become a blockbuster.

Experiencing blood streaks after a sneeze can be alarming, but it's often due to common issues like dry air, allergies, or forceful sneezes irritating delicate nasal vessels. Understanding these ...

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...

Silent Sinus Syndrome causes subtle facial changes from chronic sinus blockage Expert explains how to spot it early and ...

So, Regeneron's revenue rose 1.9% from $3.68 billion in Q2 2025 to $3.75 billion, beating consensus estimate by $160 million ...